Antipsychotic toxicity: Difference between revisions
(Text replacement - "*ECG" to "*ECG") |
ClaireLewis (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Clinical Features== | ==Clinical Features== | ||
[[File:Atypical Antipsychotic Toxicity.png|thumb|Evaluation of SGA (Second Generation Antipsychotic) Toxicity]] | [[File:Atypical Antipsychotic Toxicity.png|thumb|Evaluation of SGA (Second Generation Antipsychotic) Toxicity]] | ||
*Extrapyramidal | *[[Extrapyramidal symptoms]] | ||
**Acute | **Acute [[dystonic reaction]] | ||
***Tongue protrusion, facial grimacing, trismus, oculogyric crisis | ***Tongue protrusion, facial grimacing, trismus, oculogyric crisis | ||
**Akathisia | **Akathisia | ||
| Line 20: | Line 20: | ||
*[[ECG]] changes | *[[ECG]] changes | ||
**Sinus tachycardia | **Sinus tachycardia | ||
**QT prolongation | **[[QT prolongation]] | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 16:42, 25 September 2016
Background
- Isolated overdose of antipsychotics is rarely fatal
- Toxicity results in blockade of some or all of the following receptors:
- Dopamine - extrapyramidal symptoms
- Alpha-1 - orthostatic hypotension, reflex tachycardia
- Muscarinic - anticholinergic symptoms
- Histamine - sedation
Clinical Features
- Extrapyramidal symptoms
- Acute dystonic reaction
- Tongue protrusion, facial grimacing, trismus, oculogyric crisis
- Akathisia
- Acute dystonic reaction
- CNS
- Lethargy, ataxia, dyarthria, confusion, coma
- Seizure (1%)
- Anticholinergic Effects
- Tachycardia, dry mucous membranes, dry skin, decreased bowel sounds, delirium
- ECG changes
- Sinus tachycardia
- QT prolongation
Differential Diagnosis
Anticholinergic toxicity Causes
- Medications[1]
- Atropine
- Antihistamines
- Antidepressants
- Antipsychotics
- Muscle relaxants
- Anti-Parkinsonians
- Plants
- Jimson weed (Devil's trumpet)
- Amanita mushroom
Evaluation
Workup
- POC Glucose
- ECG (QT interval)
- Co-ingestions: serum acetaminophen, salicylate, EtOH level, other known drug levels
- Urine toxicology screen
- Chemistry (metabolic acidosis, electrolytes, renal function)
- LFT (hepatotoxicity)
- CK (rhabdomyolysis)
- Serum osmolarity (osmolar gap)
- ABG (carboxyhemoglobin, methemoglobin)
Management
Supportive
- Hypotension
- QT prolongation
- Treat all with QTc >500ms with magnesium 2-4gm IV over 10min
Extrapyramidal
- Diphenhydramine 25-50mg IV/IM OR benztropine 1-2mg IV/IM
- Oral therapy with either of above meds should be continued for 2 weeks
Disposition
- Consider discharge after 6hr as long as there are all of the following:
- No mental status changes
- Normal HR/BP
- No orthostatic hypotension
- Normal QT interval
See Also
- Neuroleptic Malignant Syndrome (NMS)
- Tardive dyskinesia
- Beta-Blocker Toxicity
- Calcium Channel Blocker Toxicity
External Links
References
- ↑ Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium – theory, evidence and practice. Br J Clin Pharmacol. 2015;81(3):516-24.